检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:尉艳霞[1] 童朝晖[1] 龚娟妮[1] 王臻[1] 王晓娟[1] 徐莉莉[1] 伍燕兵[1] 李红杰[1] 王辰[1]
机构地区:[1]首都医科大学附属北京朝阳医院-北京呼吸疾病研究所,100020
出 处:《中华结核和呼吸杂志》2010年第4期273-275,共3页Chinese Journal of Tuberculosis and Respiratory Diseases
摘 要:目的探讨胸腔积液和血清中腺苷脱氨酶(ADA)对鉴别结核性胸膜炎及恶性胸腔积液的临床价值。方法回顾性分析91例经内科胸腔镜胸膜活检病理确诊为结核性胸腔积液(结核组49例)和恶性胸腔积液(恶性组42例)患者的胸腔积液及血清中ADA活性,应用受试者工作曲线(ROC曲线)确定结核性胸膜炎患者胸腔积液ADA的最佳临界值。结果结核组胸腔积液ADA活性和胸腔积液ADA与血清ADA比值分别为(46±26)U/L和4.14-_4.0,明显高于恶性组的(16±8)U/L和1.7±1.2,差异均有统计学意义(t值分别为7.383和3.852,均P〈0.01),结核组和恶性组的血清ADA活性分别为(13±5)U/L和(124-6)U/L,差异无统计学意义(t=1.582,P〉0.05)。应用ROC曲线确定胸腔积液ADA诊断结核性胸膜炎的最佳临界值为28.7U/L,灵敏度为75.5%,特异度为95.2%。结论胸腔积液ADA活性可以作为鉴别结核性和恶性胸腔积液的重要指标,对结核性胸膜炎有较高的临床诊断价值,而血清ADA活性对鉴别两者无临床意义。Objective To investigate the clinical value of pleural fluid adenosine deaminase (ADA) activity in differentiating tuberculous pleural effusions (TPE) from malignant effusions. Methods The serum and pleural adenosine deaminase activity of 91 cases confirmed by pleural biopsy through medical thoraeoseopy were retrospectively analyzed. TPE was confirmed in d9 cases and malignant effusion in 42 cases. The optimal cutoff for TPE was determined by using the ROC curve. Results The mean pleural ADA was signifieantly ( t = 7. 383, P 〈 0. 01 ) higher in ~ (46 ± 26) U/L as compared to malignancy ( 16 ± 8 ) U/L, so was the pleural fluid/serum ADA ratio (4. 1 ± 4. 0 vs 1.76 ± 1.2, t = 3. 852, P 〈 0. 01 ), but there was no statistically significant difference between malignant and tuberculous effusion in serum ADA activity [ (13 ±5) U/L vs (12 ±6) U/L, t = 1. 582, P 〉0. 05. The cutoff value of pleural ADA for PTE was 28.7 U/L, with a sensitivity of 75. 5% and a specificity of 95.2%. Conclusions Pleural fluid, but not serum, ADA activity, can be used for the differentiation between tuberculous and malignant pleural effusions.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3